Gut Microbiota and Their Derived Metabolites, a Search for Potential Targets to Limit Accumulation of Protein-Bound Uremic Toxins in Chronic Kidney Disease
Chronic kidney disease (CKD) is characterized by gut dysbiosis with a decrease in short-chain fatty acid (SCFA)-producing bacteria. Levels of protein-bound uremic toxins (PBUTs) and post-translational modifications (PTMs) of albumin increase with CKD, both risk factors for cardiovascular morbidity a...
Guardado en:
Autores principales: | Mieke Steenbeke, Sophie Valkenburg, Tessa Gryp, Wim Van Biesen, Joris R. Delanghe, Marijn M. Speeckaert, Griet Glorieux |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0537b022e8b3467bbb75822ecd4032c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gut Microbiome Profiling Uncovers a Lower Abundance of <i>Butyricicoccus</i> in Advanced Stages of Chronic Kidney Disease
por: Tessa Gryp, et al.
Publicado: (2021) -
Gut–Kidney Axis on Chip for Studying Effects of Antibiotics on Risk of Hemolytic Uremic Syndrome by Shiga Toxin-Producing <i>Escherichia coli</i>
por: Yugyeong Lee, et al.
Publicado: (2021) -
Perfil de susceptibilidad a los antimicrobianos en cepas de E coli productoras de Shiga toxina (STEC) aisladas de infecciones humanas y de alimentos
por: Reyes S,Marcelo, et al.
Publicado: (2004) -
Acral gangrene as a presentation of non-uremic calciphylaxis
por: Muhammad Hammadah, et al.
Publicado: (2013) -
The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients
por: Kenshiro Hirata, et al.
Publicado: (2021)